LINC01844

Across TCGA pan-cancer cohorts, LINC01844 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated LINC01844 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher LINC01844 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01844 expression acts as an unfavorable survival marker, although some lineages such as SKCM and READ show a favorable association.

CESC, UVM, and SKCM are the cancer types where LINC01844 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Median	All	0.651	0.796	.003	54	view →
UVM	DFS	Median	III,IV	0.476	0.831	.007	43	view →
SKCM	OS	Quartile	All	0.394	0.185	<.001	39	view →
LGG	OS	Median	All	0.850	0.936	<.001	31	view →
READ	OS	Median	IV	0.913	0.544	.003	30	view →
BLCA	OS	Median	All	0.653	0.563	.012	20	view →
DLBC	OS	Tertile	All	1.000	0.419	.015	18	view →
KIRP	DFS	Tertile	All	0.814	0.962	.003	14	view →
KICH	OS	Median	III,IV	0.606	0.945	.014	12	view →
ACC	DFS	Tertile	III,IV	0.756	0.111	<.001	11	view →
LIHC	DFS	Quartile	All	0.452	0.565	.018	11	view →
PAAD	DFS	Tertile	All	0.148	0.417	.004	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

LINC01844–CESC (DFS)

Open the CESC breakdown →